The potential health and economic impact of implementing a medically prescribed heroin program among Canadian injection drug users

International Journal of Drug Policy

Volumn 15, Issue 4, 2004, Pages 259-263

  Miller, Cari L ^a,b   Schechter, Martin T ^a,b   Wood, Evan ^a,b   Spittal, Patricia M ^a,b   Li, Kathy ^a,b   Laliberté, Nancy ^a,b   Montaner, Julio S ^a,b   Hogg, Robert S ^a,b  

^a Brit Columbia Ctr Excell HIV/AIDS   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; ILLICIT DRUG; METHADONE;

ADULT; ARTICLE; CANADA; CONTROLLED STUDY; COST CONTROL; CRIMINAL BEHAVIOR; DRUG DEPENDENCE; DRUG USE; ECONOMIC ASPECT; EMERGENCY WARD; EMPLOYMENT; FEMALE; HEALTH CARE COST; HEALTH ECONOMICS; HEALTH PROGRAM; HOSPITAL COST; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT FAILURE;

EID: 4143092552     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2004.04.001     Document Type: Article

References (19)

1. Bammer G., Douglas R.M. The ACT heroin trial proposal: An overview. The Medical Journal of Australia. 164:1996;690-692
2. Bruneau J., Lamothe F., Franco E., Lachance N., Desy M., Soto J., et al. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: Results of a cohort study. American Journal of Epidemiology. 146(12):1997;994-1002
3. Farrell M., Hall W. The Swiss heroin trials: Testing alternative approaches. BMJ. 316(7132):1998;639
4. Fischer B., Rehm J. The case for a heroin substitution treatment trial in Canada. Canadian Journal of Public Health (Revue Canadienne de Sante Publique). 88(6):1997;367-370
5. Hall W.D., Kimber J., Mattick R.P. Breaking the deadlock over an Australian trial of injectable opiod maintenance. The Medical Journal of Australia. 176:2002;72-73
6. Health Canada (1999). Canadian profile: Alcohol, tobacco and other drugs. Ottawa: Canadian Centre on Substance Abuse.
7. Office of the Auditor General (2001). Illicit drugs: The federal government's role. In 2001 Report of the Auditor General of Canada, Office of the Auditor General, Ottawa. Available at: http://www.oag-bvg.gc.ca/domino/ (accessed October 16, 2002).
8. Palepu A., Tyndall M.W., Leon H., Muller J., O'Shaughnessy M.V., Schechter M.T., et al. Hospital utilization and costs in a cohort of injection drug users. Canadian Medical Association Journal. 165(4):2001;415-420
9. Rehm J.G.P., Steffen T., Gutzwiller F., Dobler-Mikola A., Uchtenhagen A. Feasibility, safety, and efficacy of injectable heroin prescription for refractory opiod addicts: A follow-up study. The Lancet. 358:2001;1417-1420
10. Remis, R. S., Leclerc, P., Routledge, R., Taylor, C., Bruneau, J., Beauchemin, J., et al. (1998, March). Consortium to characterize injection drug users in Canada. Montreal, Toronto, Vancouver: Health Canada.
11. Schechter M.T., Strathdee S.A., Cornelisse P.G., Currie S., Patrick D.M., Rekart M.L., et al. Do needle exchange programmes increase the spread of HIV among injection drug users? An investigation of the Vancouver outbreak. AIDS. 13(6):1999;F45-F51
12. Strathdee S.A., Patrick D.M., Archibald C.P., Ofner M., Cornelisse P.G., Rekart M., et al. Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada. Addiction. 92(10):1997;1339-1347
13. Strathdee S.A., Patrick D.M., Currie S.L., Cornelisse P.G., Rekart M.L., Montaner J.S., et al. Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. AIDS. 11(8):1997;F59-F65
14. Uchtenhagen, A., AD-M, Steffen, T., Gutzwiller, F., Blattler, R., Pfeifer, S. (Eds.) (1999). Prescription of narcotics for heroin addicts main results of the Swiss National Cohort Study. Zurich: Karger.
15. Van den Brink W., Hendriks V.M., Blanken P., Koeter M.W.J., van Zwieten B.J., van Ree J.M. Medical prescription of heroin to treatment resistant heroin addicts: Two randomised controlled trials. British Medical Journal. 327:2003;310-316
16. Wall R., Rehm J., Fischer B., Brands B., Gliksman L., Stewart J., et al. Social costs of untreated opioid dependence. Journal of Urban Health. 77(4):2000;688-722
17. WHO (1998, June). Report on the global HIV/AIDS epidemic. Geneva: World Health Organization.
18. Wood E., Tyndall M.W., Spittal P.M., Li K., Kerr T., Hogg R.S., et al. Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help? Canadian Medical Association Journal. 165(4):2001;405-410
19. Zunzunegui M.V. Is the medical prescription of heroin a treatment option for heroin addiction? The PEPSA Team (The Experimental Program of Narcotic Prescription in Andalucia). Medicina Clinica. 113(6):1999;219-221